No adverse effects of B12 toxicity have ever been recorded from taking excessive amounts of B12
If you are considering this path, credible researchers emphasize the following: Sequencing Matters: Some practitioners introduce BPC-157 first to establish GI resilience before initiating GLP-1 therapy, anticipating the nausea many patients experience early on
Individuals receiving therapeutic B12 injections constitute the primary at-risk group
Pregnancy and breastfeeding increase B12 requirements, and pregnant women with B12 deficiency may need more frequent monitoring and potentially adjusted treatment schedules
50 mg per vial Purity: 99% (HPLC verified) Container: sealed glass vial (lyophilized powder) Certificate of Analysis: lot-specific COA available See the FDA Disclosure, Storage Instructions, and RUO tabs for handling, storage, and regulatory information
This enhanced bioavailability makes these injections particularly effective for individuals following reduced-calorie diets